Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

US-India Trade Deal AT A STANDSTILL? India Awaits Crucial Response as Key Issues Spark Tensions!

Economy

|

Updated on 11 Nov 2025, 03:10 pm

Whalesbook Logo

Reviewed By

Abhay Singh | Whalesbook News Team

Short Description:

India is awaiting a response from the United States on its proposed bilateral trade deal, believing no further negotiation rounds are necessary. While progress is noted, sticking points include India's Russian oil imports, which the US wants stopped, and US demands for market access in India's sensitive agriculture and dairy sectors. India emphasizes its energy security and historical ties with Russia, while also seeking a rollback of US tariffs imposed on it.
US-India Trade Deal AT A STANDSTILL? India Awaits Crucial Response as Key Issues Spark Tensions!

▶

Detailed Coverage:

India is nearing the conclusion of its bilateral trade agreement (BTA) negotiations with the United States and is currently awaiting the US response to its latest proposal. Government sources indicate that India has safeguarded its sensitive sectors within this proposal and anticipates that another round of talks may not be required. U.S. President Donald Trump has previously acknowledged significant progress, aiming for a fair and balanced agreement.

However, a major obstacle remains India's continued purchase of oil from Russia, a move the US wants India to cease, citing its role in fueling the war in Ukraine. India counters that it must not be singled out and prioritizes its energy security, highlighting its strong historical relationship with Russia. The US has imposed a 50% duty on certain Indian goods, with 25% attributed as a penalty for Russian oil purchases; India seeks a complete rollback of this penalty and reciprocal tariff reductions to gain a competitive edge against countries like Vietnam and Bangladesh, which face lower duties.

Another point of contention is the US demand for increased market access in India's agriculture and dairy sectors, particularly for genetically modified soya and corn, which India currently restricts.

Impact: This trade negotiation's outcome could significantly influence India's trade balance, import/export dynamics, and the competitiveness of its key sectors like agriculture, dairy, and energy in the US market. Investor sentiment towards Indian companies involved in these sectors may also be affected. Rating: 7/10

Difficult Terms: Bilateral Trade Agreement (BTA): An agreement on trade signed between two countries. Genetically Modified (GM): Organisms whose genetic material has been altered using genetic engineering techniques.


Healthcare/Biotech Sector

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

India's Pharma Powerhouse Cracks China: Massive Diabetes Drug Deals Signed!

India's Pharma Powerhouse Cracks China: Massive Diabetes Drug Deals Signed!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

JB Pharma Q2 Profit SOARS 19%! Revenue Jumps 8.4%! Is This Your Next Big Investment?

JB Pharma Q2 Profit SOARS 19%! Revenue Jumps 8.4%! Is This Your Next Big Investment?

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

India's Pharma Powerhouse Cracks China: Massive Diabetes Drug Deals Signed!

India's Pharma Powerhouse Cracks China: Massive Diabetes Drug Deals Signed!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

JB Pharma Q2 Profit SOARS 19%! Revenue Jumps 8.4%! Is This Your Next Big Investment?

JB Pharma Q2 Profit SOARS 19%! Revenue Jumps 8.4%! Is This Your Next Big Investment?

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?


Commodities Sector

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?